Vivendi SE
XMUN:VVU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vivendi SE
XMUN:VVU
|
FR |
|
Next Biometrics Group ASA
F:NT7
|
NO |
|
T
|
Textron Inc
XMUN:TXT
|
US |
|
S
|
Sprouts Farmers Market Inc
F:1FA
|
US |
|
Laboratorios Farmaceuticos ROVI SA
OTC:LABFF
|
ES |
|
F
|
FMC Corp
XMUN:FMQ
|
US |
|
P
|
Pandora A/S
XMUN:3P7
|
DK |
|
Fresh Del Monte Produce Inc
NYSE:DMC
|
KY |
Wall St Price Targets
VVU Price Targets Summary
Vivendi SE
According to Wall Street analysts, the average 1-year price target for VVU is 2.83 EUR with a low forecast of 2.102 EUR and a high forecast of 3.434 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VVU's stock price target?
Price Target
2.83
EUR
According to Wall Street analysts, the average 1-year price target for VVU is 2.83 EUR with a low forecast of 2.102 EUR and a high forecast of 3.434 EUR.
What is the Revenue forecast for Vivendi SE?
Projected CAGR
3%
Over the last 14 years, the compound annual growth rate for Revenue has been -28%. The projected CAGR for the next 3 years is 3%.
What is the Gross Profit forecast for Vivendi SE?
Projected CAGR
778%
Over the last 14 years, the compound annual growth rate for Gross Profit has been -30%. The projected CAGR for the next 2 years is 778%.
What is the Pre-Tax Income forecast for Vivendi SE?
Projected CAGR
86%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been -32%. The projected CAGR for the next 3 years is 86%.
What is the Net Income forecast for Vivendi SE?
Projected CAGR
94%
Over the last 14 years, the compound annual growth rate for Net Income has been -30%. The projected CAGR for the next 3 years is 94%.
